NCT05304364View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

March 22, 2022

Primary Completion Date

October 21, 2022

Study Completion Date

November 19, 2022

Conditions

Opiod Use Disorder

Interventions

COMBINATION_PRODUCT

Combination Product: Naltrexone

Naltrexone Implant

Trial Locations (1)

5000

CMAX, Adelaide

All Listed Sponsors

lead

Delpor, Inc.

INDUSTRY